Chemokine receptor allelic polymorphisms: Relationships to HIV resistance and disease progression

Seminars in Immunology

Volumn 10, Issue 3, 1998, Pages 187-194

  Paxton, William A ^a   Kang, Stanley ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chemokine receptors; HIV 1; Pathogenesis; Polymorphism; Resistance

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; GLYCOPROTEIN GP 120;

ARTICLE; DISEASE COURSE; DNA POLYMORPHISM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

EID: 0032103577     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0132     Document Type: Article

References (55)

1. 1. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane domain, G protein-coupled receptor. Science 272:872-877
2. 2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: ARANTES, MIP-1 α, MIP-1 β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958
3. 3. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996) The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148
4. 4. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, DiMarzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666
5. 5. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158
6. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673
7. 7. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR (1997) Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 185:621-628
8. 8. Simmons G, Wilkinson D, Reeves JD, Dittman MT, Beddows S, Weber J, Carnegis G, Gesselberger U, Gray PW, Weiss RA, Clapham PR (1996) Primary syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 70:8355-8360
9. 9. Reeves JD, McKnight A, Potempa S, Simmons G, Gray PW, Power CA, Wells T, Weiss RA, Talbot SJ (1997) CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 231:130-134
10. 10. Deng H, Unutmaz D, KewalRamani VN, Littman DR (1997) Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300
11. 11. Farzan M, Choe H, Martin K, Marcon L, Hofmann W, Karlsson G, Sun Y, Barrett P, Marchand N, Sullivan N, Gerard N, Gerard C, Sodroski J (1997) Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 186:405-411
12. 12. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, Farber JM (1997) STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T-cell line-fusion HIV-1. J Exp Med 185:2015-2023
13. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type-1 infected individuals. J Virol 67:1772-1777
14. 14. Fauci AS (1996) Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534
15. 15. Fenyo E, Morfeldt-Mason L, Chiodi F, Lind B, VonGegerfelt A, Albert J, Asjo B (1988) Distinctive replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 62:4414-4419
16. + cell depletion and progression to AIDS. Ann Int Med 118:681-688
17. 17. Schuitemaker H, Koot M, Koostra NA, Dercksen MW, DeGoude REY, van Steenwijk RP, Lange JMA Schattenkerk JKME, Miedema F, Tersmette M (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic populations. J Virol 66:1354-1360
18. 18. Tersmette M, DeGoude REY, Al BJM, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F (1998) Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency virus syndrome (AIDS) and AIDS-related complex. J Virol 62:2026-2032
19. 19. Tersmette M, Gruters RA, DeWolf F, DeGoude REY, Lange JMA, Schellekens PTA, Goudsmit J, Huisman HG, Miedema F (1989) Evidence for a role of a virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency virus syndrome: studies on sequential isolates. J Virol 63:2118-2125
20. 20. Tersmette M, Lange JMA, DeGoude REY, DeWolf F, Schattenkerk JKME, Schellekens PTA, Coutinho RA, Huisman HG, Goudsmit J, Miedema F (1989) Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i(8645):983-985
21. 21. Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, Fenyo EM (1997) Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 71:7478-7487
22. 22. Levy JA (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183-289
23. + T-cell levels. AIDS 7:1159-1166
24. 24. Farzadegan H, Henrard DR, Kleeberger CA, Schrager L, Kirby AJ, Saah AJ, Rinaldo CRJ, O'Gorman M, Detels R, Taylor E, Phair JP, Margolick JB (1996) Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. J AIDS 13:448-455
25. 25. Keet IP, Krijnen P, Koot M, Lange JMA, Miedema F, Goudsmit J, Coutinho RA (1993) Predictors of rapid progression to AIDS in HIV-1 seroconvertors. AIDS 7:51-57
26. 26. Klein MR, Miedema F (1995) Long-term survivors of HIV-1 infection. Trends Microbiol 3:386-391
27. + cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA 92:11135-11139
28. 28. Cao Y, Qin L, Zhang L, Safrit J, Ho DD (1995) Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 332:201-208
29. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126:946-954
30. 30. Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170
31. 31. Alkhatib G, Ahuja SS, Light D, Mummidi S, Berger EA, Ahuja SK (1997) CC chemokine receptor-5 mediated signaling and HIV-1 co-receptor activity share common structural determinants. J Biol Chem 32:19771-19776
32. 32. Atchison RE, Gosling J, Monteclaro FS, Franci C, Digilio L, Charo IF, Goldsmith MA (1996) Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274:1924-1926
33. 33. Bieniasz PD, Friedell RA, Aramoni I, Ferguson SSG, Caron MG, Cullen BR (1997) HIV-1 induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 coreceptor. EMBO J 16:2599-2609
34. 34. Doranz BJ, Lu Z, Rucker J, Zhang T, Sharron M, Cen Y, Wang Z, Guo H, Du J, Accavitti MA, Doms RW, Peiper SC (1997) Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J Virol 71:6305-6314
35. 35. Farzan M, Choe H, Martin KA, Sun Y, Sidelko M, Mackay CR, Gerard NP, Sodroski J, Gerard C (1997) HIV-1 entry and macrophage inflammatory protein-1b-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem 272:6854-6857
36. 36. Gosling J, Monteclaro FS, Atchison RE, Arai H, Tsou C, Goldsmith MA, Charo IF (1997) Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc Natl Acad Sci USA 94:5061-5066
37. 37. Rucker J, Samson M, Doranz BJ, Libert F, Benson JF, Yi Y, Smyth RJ, Collman RG, Broder CC, Vassart G, Doms RW, Parmentier M (1996) Regions in b-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437-446
38. 38. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, Moore JP (1996) CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5. Nature 384:184-187
39. 39. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A Cardoso AA Desjardin E, Newman W, Gerard C, Sodroski J (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183
40. 40. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA (1996) Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat Med 2:412-417
41. + T cells. Science 270:1811-1815
42. 42. Liu R, Paxton WA, Choe S, Ceradini D, Marin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377
43. 43. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ (1996) Genetic resistance of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862
44. 44. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber C-M, Saragosti S, Lapoumroulie C, Cogniaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M (1996) Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR5 receptor gene. Nature 382:722-755
45. 45. Zimmerman PA, Buckler-White A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohen O, Rubbert A, Lam G, Vaccarezza M, Kennedy PE, Kumaraswami V, Giorgi JV, Detels R, Hunter J, Chopek M, Berger EA, Fauci AS, Nutman TB, Murphy PM (1997) Inherited resistance to HIV-1 conferred by an in activating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 3:23-36
46. 46. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Caradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 2:1240-1243
47. 47. Biti R, French R, Young J, Bennetts B, Stewart G (1997) HIV-1 infection in an individual homozygous for the CCR5 deletion mutant. Nat Med 3:252-253
48. 48. O'Brien TR, Winkler C, Dean M, Nelson JA, Carr E (1997) HIV-1 infection in a man homozygous for CCR5 delta-32. Lancet 349:1219
49. 49. Theodorou I, Meyer L, Magierowska M, Katlana C, Rouzioux C (1997) HIV-1 infection in an individual homozygous for CCR5 delta-32. Lancet 349:1219
50. 50. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, Mackay CR (1997) CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 185:1681-1691
51. 51. Picchio GR, Gulizia RJ, Mosier DE (1997) Chemokine receptor CCR5 genotype influences for kinetics of human immunodeficiency type 1 infection in human PBL-SCID mice. J Virol 71:7124-7127
52. 52. Ansari-Lari MA, Liu X, Metzker ML, Rut AR, Gibbs RA (1997) The extent of genetic variation in the CCR5 gene. Nat Genet 16:221-222
53. 53. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study, O'Brien SJ (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959-965
54. 54. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P (1996) The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 2:1244-1247
55. 55. Amara A, Le Gall S, Schwartz O, Salamero J, Montes M, Loetscher P, Bagglioni M, Virelizier J, Arenana-Seisdedos F (1997) HIV coreceptor downregulation as antiviral principle: SDF-1 α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 186:139-146